ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Cash from Investing Activities of $450000.0 for Q1 2026, up 2704.17% year-over-year from $16047.5 in Q1 2025, and up 115.0% quarter-over-quarter from -$3.0 million in Q4 2025.
ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Cash from Investing Activities for 10 consecutive years, with $450000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 2704.17% year-over-year to $450000.0; the TTM figure through Mar 2026 stood at -$2.6 million (down 40505.1% YoY), while the FY2025 annual figure was -$3.0 million, down 23479.87% from the prior year.
- Cash from Investing Activities advanced to $450000.0 in Q1 2026 per NDRA's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $450000.0 in Q1 2026 and bottomed at -$3.0 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged -$255215.8 across 5 years, with a median of -$23796.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 98.56% — and 2026, when it soared 2704.17%.
- ENDRA Life Sciences' Cash from Investing Activities stood at -$38563.0 in 2022, then surged by 105.91% to $2279.0 in 2023, then jumped by 382.67% to $11000.0 in 2024, then tumbled by 27372.73% to -$3.0 million in 2025, then jumped by 115.0% to $450000.0 in 2026.
- Business Quant data shows NDRA's Cash from Investing Activities at $450000.0 in Q1 2026, -$3.0 million in Q4 2025, and -$17280.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -25.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -366.20 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22 Mn |
| Jun 30, 2026 | 2.22 Mn |
| Mar 31, 2026 | 450,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Dec 31, 2025 | -3.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -17,280.00 |
| Mar 31, 2025 | -17,280.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | -23,796.00 |
| Mar 31, 2024 | -23,796.00 |
| Dec 31, 2023 | 2,279.00 |
| Dec 31, 2023 | 2,279.00 |
| Mar 31, 2023 | -27,000.00 |
| Mar 31, 2023 | -27,000.00 |
| Dec 31, 2022 | -38,563.00 |
| Dec 31, 2022 | -38,563.00 |
| Sep 30, 2022 | -14,861.00 |
| Sep 30, 2022 | -14,861.00 |